Shandong Xinhua Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Shandong Xinhua Pharmaceutical has a total shareholder equity of CN¥5.0B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 26.3%. Its total assets and total liabilities are CN¥8.5B and CN¥3.5B respectively. Shandong Xinhua Pharmaceutical's EBIT is CN¥482.9M making its interest coverage ratio 27.6. It has cash and short-term investments of CN¥922.1M.
Key information
26.3%
Debt to equity ratio
CN¥1.31b
Debt
Interest coverage ratio | 27.6x |
Cash | CN¥922.05m |
Equity | CN¥4.99b |
Total liabilities | CN¥3.48b |
Total assets | CN¥8.47b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XIN's short term assets (CN¥3.5B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: XIN's short term assets (CN¥3.5B) exceed its long term liabilities (CN¥1.0B).
Debt to Equity History and Analysis
Debt Level: XIN's net debt to equity ratio (7.9%) is considered satisfactory.
Reducing Debt: XIN's debt to equity ratio has reduced from 46% to 26.3% over the past 5 years.
Debt Coverage: XIN's debt is well covered by operating cash flow (37.1%).
Interest Coverage: XIN's interest payments on its debt are well covered by EBIT (27.6x coverage).